Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 1
2013 1
2014 3
2015 3
2016 1
2017 2
2018 1
2019 9
2020 9
2021 30
2022 10
Text availability
Article attribute
Article type
Publication date

Search Results

65 results
Results by year
Filters applied: . Clear all
Page 1
Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19.
Wheatley AK, Juno JA, Wang JJ, Selva KJ, Reynaldi A, Tan HX, Lee WS, Wragg KM, Kelly HG, Esterbauer R, Davis SK, Kent HE, Mordant FL, Schlub TE, Gordon DL, Khoury DS, Subbarao K, Cromer D, Gordon TP, Chung AW, Davenport MP, Kent SJ. Wheatley AK, et al. Among authors: juno ja. Nat Commun. 2021 Feb 19;12(1):1162. doi: 10.1038/s41467-021-21444-5. Nat Commun. 2021. PMID: 33608522 Free PMC article.
Suboptimal SARS-CoV-2-specific CD8+ T cell response associated with the prominent HLA-A*02:01 phenotype.
Habel JR, Nguyen THO, van de Sandt CE, Juno JA, Chaurasia P, Wragg K, Koutsakos M, Hensen L, Jia X, Chua B, Zhang W, Tan HX, Flanagan KL, Doolan DL, Torresi J, Chen W, Wakim LM, Cheng AC, Doherty PC, Petersen J, Rossjohn J, Wheatley AK, Kent SJ, Rowntree LC, Kedzierska K. Habel JR, et al. Among authors: juno ja. Proc Natl Acad Sci U S A. 2020 Sep 29;117(39):24384-24391. doi: 10.1073/pnas.2015486117. Epub 2020 Sep 10. Proc Natl Acad Sci U S A. 2020. PMID: 32913053 Free PMC article.
CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity.
Nguyen THO, Rowntree LC, Petersen J, Chua BY, Hensen L, Kedzierski L, van de Sandt CE, Chaurasia P, Tan HX, Habel JR, Zhang W, Allen LF, Earnest L, Mak KY, Juno JA, Wragg K, Mordant FL, Amanat F, Krammer F, Mifsud NA, Doolan DL, Flanagan KL, Sonda S, Kaur J, Wakim LM, Westall GP, James F, Mouhtouris E, Gordon CL, Holmes NE, Smibert OC, Trubiano JA, Cheng AC, Harcourt P, Clifton P, Crawford JC, Thomas PG, Wheatley AK, Kent SJ, Rossjohn J, Torresi J, Kedzierska K. Nguyen THO, et al. Among authors: juno ja. Immunity. 2021 May 11;54(5):1066-1082.e5. doi: 10.1016/j.immuni.2021.04.009. Epub 2021 Apr 15. Immunity. 2021. PMID: 33951417 Free PMC article.
Boosting immunity to COVID-19 vaccines.
Juno JA, Wheatley AK. Juno JA, et al. Nat Med. 2021 Nov;27(11):1874-1875. doi: 10.1038/s41591-021-01560-x. Nat Med. 2021. PMID: 34764485 No abstract available.
Translating viral vaccines into immunity.
Juno JA, O'Connor SL. Juno JA, et al. Science. 2021 Jan 29;371(6528):460-461. doi: 10.1126/science.abf8121. Science. 2021. PMID: 33510011 No abstract available.
Immune imprinting and SARS-CoV-2 vaccine design.
Wheatley AK, Fox A, Tan HX, Juno JA, Davenport MP, Subbarao K, Kent SJ. Wheatley AK, et al. Among authors: juno ja. Trends Immunol. 2021 Nov;42(11):956-959. doi: 10.1016/j.it.2021.09.001. Epub 2021 Sep 15. Trends Immunol. 2021. PMID: 34580004 Free PMC article.
Tear antibodies to SARS-CoV-2: implications for transmission.
Selva KJ, Davis SK, Haycroft ER, Lee WS, Lopez E, Reynaldi A, Davenport MP, Kent HE, Juno JA, Chung AW, Kent SJ. Selva KJ, et al. Among authors: juno ja. Clin Transl Immunology. 2021 Nov 1;10(11):e1354. doi: 10.1002/cti2.1354. eCollection 2021. Clin Transl Immunology. 2021. PMID: 34754451 Free PMC article.
65 results